# Communication During Hospitalization About Resuscitation Trial

> **NCT02984124** · PHASE2,PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **University of Vermont** · enrollment: 182 (actual)

## Conditions studied

- Severe Life-limiting COPD
- Severe Life-limiting Heart Failure
- Severe Life-limiting Cirrhosis
- Severe Life-limiting Malignancy
- Severe Functional Impairment
- End Stage Renal Disease

## Interventions

- **BEHAVIORAL:** Informed Assent Discussion
- **BEHAVIORAL:** Usual Care with Attention Control

## Key facts

- **NCT ID:** NCT02984124
- **Lead sponsor:** University of Vermont
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2016-12
- **Primary completion:** 2023-03
- **Final completion:** 2025-12
- **Target enrollment:** 182 (ACTUAL)
- **Last updated:** 2025-02-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02984124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02984124, "Communication During Hospitalization About Resuscitation Trial". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02984124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*